Member Contact: Deanne Porter
Position: Clinical Project Manager
Industry: R&D Services
The CLINICAL TRIAL Company Group™ (TCTC Group™) is a privately owned, full-service global Clinical Contract Research Organization providing professional support to pharmaceutical, biotechnology, medical device and academic businesses and institutions. The company was incorporated in 2002 as The CLINICAL TRIAL Company™. TCTC Group™ has 7 different divisions each one addressing a different need and offering stand-alone services or full-service trial programmes, which optimise the integration of the client’s expertise with our own.
Our company's professional approach provides cutting edge solutions in order to move clinical trials forward and provide exceptional services to our clients. Our philosophy is one of teamwork, positivity, communication, responsibility and adding value. We conduct clinical trials of all sizes in all therapeutic areas with a particular expertise in advanced therapies, such as cell and gene therapies, as well as Orphan drugs, CNS, and medical devices. TCTC successfully executed clinical trials for the first Gene therapy to be approved in Europe. This approval trailblazes the way for other gene therapies in development and strengthens TCTC’s reputation as a leader in the field of Advanced Therapy Clinical Trials.
Our senior-level personnel, with many years' experience in the pharmaceutical industry, can provide all the essential insights required for a successful clinical trial or trial programme, completing your trial(s) on time and within budget and working closely with you in getting your product to a trade sale or market.
TCTC has been inspected by the UK MHRA and has a current certificate of compliance. There were no critical or major findings observed during the inspection.
The Company operates an ISO 9001:2015 Quality Management System.